INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 45h ago
House PTR5h ago
SEC 13F5h ago
Robinhood Chain5h ago

Results

77,421 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
KB
Kosacz BarbaraDirector
LONALeonaBio, Inc.
Grant or award
A—
28.0K sh
Apr 9, 2026Apr 13, 2026
Page 1155 of 1936
← PrevNext →
traded Apr 9, 2026
+4d
SEC Form 4

Evidence

9
TY
Teng Song-YuanDirector, Chief Executive Officer (Asia)
NCRANOCERA, INC.
Grant or award
A—
600.0K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

9
WS
Warzala Richard SDirector
ALOTAstroNova, Inc.
Grant or award
A—
2,827 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
LB
Langan BrianSee Remarks
CRAICRA INTERNATIONAL, INC.
Grant or award
A—
911 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
MP
Monahan Michael P.Chief Financial Officer
SKINBeauty Health Co
Tax withholding
F$25K
26.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
DR
Driscoll RimmaExecutive Vice President
ZTSZoetis Inc.
Grant or award
A$1,038
26 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
EK
Esch KevinExecutive Vice President
ZTSZoetis Inc.
Grant or award
A$55.28
1 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
LR
Lagano RoxanneExecutive Vice President
ZTSZoetis Inc.
Grant or award
A$22K
551 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
CG
Creed GregDirector
ARMKAramark
Grant or award
A$34K
787 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
LE
Laughter John EEVP & Chief of Operations
DALDELTA AIR LINES, INC.
Option exercise
M—
9,080 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
HM
Holmes Chad MEVP AND CHIEF CORP DEV OFFICER
CRAICRA INTERNATIONAL, INC.
Grant or award
A—
1,579 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
LE
Laughter John EEVP & Chief of Operations
DALDELTA AIR LINES, INC.
Option exercise
M—
13.5K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
FA
Filson Sean AndrewDirector
NCRANOCERA, INC.
Grant or award
A—
100.0K sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

9
GD
Gray James DChief Financial Officer
LWLamb Weston Holdings, Inc.
Grant or award
A—
99.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
YD
Yellin Jonathan DEVP AND GENERAL COUNSEL
CRAICRA INTERNATIONAL, INC.
Grant or award
A—
1,396 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
SI
Solomon Lance I.Chief Product Officer
MYNDMynd.ai, Inc.
Tax withholding
F$3,414
10.7K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
MB
Mulroy BrianChief Financial Officer
SEMRSEMrush Holdings, Inc.
Tax withholding
F$47K
3,941 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
LS
Lewis SheriCSO and COO
SKINBeauty Health Co
Tax withholding
F$23K
24.9K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

9
BJ
Bolton JeffreyDirector
EHABEnhabit, Inc.
Grant or award
A$37K
2,680 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

9
KG
Krause Allyson G.General Counsel
MYNDMynd.ai, Inc.
Tax withholding
F$6,646
20.8K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

8
OC
O'Connor CaseyChief Legal Officer
SFIXStitch Fix, Inc.
Open-market sale · 10b5-1 plan
SELL$185K
60.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

8
MR
Moat RossCHIEF OPERATING OFFICER
KNSAKiniksa Pharmaceuticals International, plc
Open-market sale · 10b5-1 plan
SELL$80K
1,703 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

7
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

6
RM
Rodman David MalcomChief Medical Officer
MLYSMineralys Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$59K
2,170 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

5
SP
Shetty Reshma P.Director, See remarks, 10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
251.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

5
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Option exercise · 10b5-1 plan
M$384K
35.7K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

5
CB
Canton Barry10% Owner
DNAGinkgo Bioworks Holdings, Inc.
Option exercise
M—
251.8K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

5
RR
Renninger RobertCHIEF FINANCIAL OFFICER
LONALeonaBio, Inc.
Grant or award
A—
300.0K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

5
FL
Freemen-Bosworth LaurenEVP/Gen Counsel & Corp Sec
PBIPITNEY BOWES INC /DE/
Open-market sale · 10b5-1 plan
SELL$7,970
693 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

4
PC
Perducat CyrilSVP, Chief Technology Officer
ROKROCKWELL AUTOMATION, INC
Option exercise · 10b5-1 plan
M—
581 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

4
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
3,093 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

4
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

3
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Derivative conversion · 10b5-1 plan
C—
42.4K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

3
PO
Pomel OlivierDirector, Chief Executive Officer
DDOGDatadog, Inc.
Option exercise · 10b5-1 plan
M—
38.1K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

3
EM
Erlinger Joseph M.President, McDonald's USA
MCDMCDONALDS CORP
Option exercise · 10b5-1 plan
M—
2,626 sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

2
Yuan Eric S.Director, Chief Executive Officer
ZMZoom Communications, Inc.
Grant or award
A—
561.6K sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC Form 4

Evidence

1
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$39K
500 sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

1
RG
Rosenbaum Michael GeorgeDirector, Chief Executive Officer
GWREGuidewire Software, Inc.
Open-market sale · 10b5-1 plan
SELL$143K
1,200 sh
Apr 13, 2026Apr 13, 2026
traded Apr 13, 2026
+0dSEC Form 4

Evidence

0
NS
Nagendran SukumarDirector, President and Head of R&D
TSHATaysha Gene Therapies, Inc.
Option exercise · 10b5-1 plan
M$33K
19.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence

0
HR
Howard Justyn RussellDirector, Executive Chair, 10% Owner
SPTSprout Social, Inc.
Derivative conversion · 10b5-1 plan
C—
40.0K sh
Apr 10, 2026Apr 13, 2026
traded Apr 10, 2026
+3dSEC Form 4

Evidence